THE STRONG PERFORMANCE OF THE GROUP CONTINUES IN THE FIRST QUARTER OF 2024: REVENUE +10 2%, EBITDA +10 5%, ADJUSTED NET INCOME +5 6% marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Kyowa Kirin Co., Ltd. (TSE: 4151) a Japan-based global specialty pharmaceutical company (J-GSP) creating innovative medical solutions utilizing.
This is an unofficial English Language courtesy translation of the original Italian report prepared and issued in Italian by the Board of Statutory Auditors of Recordati S.p.A . . | March 30, 2023